Skip to main content
. Author manuscript; available in PMC: 2021 Aug 24.
Published in final edited form as: Colorectal Dis. 2020 Jun 14;22(10):1314–1324. doi: 10.1111/codi.15113

Table 5. Survival time (in years) for all patients, from randomization.

Survival quantiles
Patient group Min. 25% (95% CI) 50% (95% CI) 75% (95% CI) Max.
Control Group 1 (N = 47) 0.59 2.74 (1.53–3.32) 3.78 (3.10–4.64) 5.63 (4.48 to Inf) 9.05
Metastasectomy Group 2 (N = 46) 0.17 2.90 (1.83–3.35) 3.53 (3.11–6.58) 7.46 (4.10 to Inf) 9.07

Inf, Infinity.